Erwin S.
- Country
- Belgium
- Department
- Dermatology
Research Overview
- A Randomized Controlled Trial Comparing Proactive Therapeutic Drug Monitoring with Routine Care Using Secukinumab, Ixekizumab, or Guselkumab in Moderate-to-Severe Psoriasis
- Efficacy and Safety of Ruxolitinib Cream in Adults with Moderate Atopic Dermatitis: A Phase 3b Double-Blind, Randomized, Vehicle-Controlled Study
Data & Insights
Has run more than one trial at 5 of 60 partner sites.
Specializations
Psoriasis and biologic therapy
The clinical research activity centers on moderate-to-severe psoriasis, with emphasis on optimizing treatment using novel biologic agents such as secukinumab, ixekizumab, and guselkumab. The therapeutic focus includes sustained disease control and treatment responsiveness in patients managed within dermatology practice.
- Biologic treatment optimization
- Therapeutic drug monitoring
- PASI-based disease control
Interest in psoriasis care is directed toward improving long-term management strategies in immune-mediated skin disease.
Atopic dermatitis and topical anti-inflammatory therapy
Another major area of activity is atopic dermatitis, particularly moderate atopic dermatitis requiring advanced topical management. The investigator is involved in studies evaluating ruxolitinib cream for patients with inadequate response to, intolerance of, or contraindications to topical corticosteroids and topical calcineurin inhibitors.
- Topical JAK inhibition
- Inflammatory skin disease
- Nonsteroidal dermatologic treatment
This work reflects a therapeutic interest in expanding options for patients needing alternatives to conventional topical therapy.
Biologic immunomodulation in eczema
The investigator also participates in research on rocatinlimab for moderate-to-severe atopic dermatitis, including use alongside topical corticosteroids and/or topical calcineurin inhibitors. The clinical focus includes outcomes measured through established dermatologic severity assessments such as vIGA-AD and EASI.
- T-cell–targeted therapy
- Eczema severity assessment
- Combination anti-inflammatory treatment
These studies align with an interest in immune-directed approaches for chronic eczematous disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.